Pharsight

Drugs that contain Latanoprostene Bunod

1. Vyzulta patents expiration

VYZULTA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8058467 BAUSCH AND LOMB Prostaglandin derivatives
Jan, 2025

(10 months from now)

US7910767 BAUSCH AND LOMB Prostaglandin derivatives
Jan, 2025

(10 months from now)

US7273946 BAUSCH AND LOMB Prostaglandin derivatives
Oct, 2025

(1 year, 7 months from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7629345 BAUSCH AND LOMB Prostaglandin derivatives
Jan, 2025

(10 months from now)

Market Authorisation Date: 02 November, 2017

Treatment: Reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of VYZULTA before it's drug patent expiration?
More Information on Dosage

VYZULTA family patents

Family Patents